Vor Biopharma revises stock option exercise prices
Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...
Townhall27d
The Race to Dominate Biotechnology Innovation
The exercise of march in rights by the U.S. government would be a body blow to the U.S. biotechnology research infrastructure, as no company would partner with a U.S. university that had received ...
Yahoo Finance24d
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited ... including the exercise of the over-allotment, totaled $6.9 million, before deducting underwriting ...
Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
BofA Securities, Goldman Sachs & Co. LLC, Evercore ISI, Guggenheim Securities and Cantor acted as joint bookrunners for the offering.